Medical writing market to be valued at $10.5b by 2032

Thanks to the growing demand for well-organised regulatory documentation.

The medical writing market is projected to reach $10.5b by 2032 at a compound annual growth rate of 10.45%, according to SNS Insider.

The sector’s expansion is attributed to the growing demand for well-organised regulatory and scientific documentation for medication approvals, clinical trials, and commercialisation procedures.

Contract research organisations, biotechnology businesses, and pharmaceutical firms are increasingly outsourcing medical writing to meet evolving FDA, EMA, and ICH regulations.

“Demand is being driven even further by the worldwide explosion of clinical trials funded by government programmes such as the FDA's Clinical Data Summary Pilot Program and the EU Clinical Trials Regulation,” the report said.